BrainsWay will be participating in the ISAM Global Addiction Therapeutics Innovation Day (GATID), taking place on September 30, 2026, in Rotterdam, the Netherlands.
Dr. Colleen A. Hanlon, PhD, Vice President of Global Medical Affairs at BrainsWay, will deliver a featured presentation on the role of TMS in advancing addiction treatment.
For full event details, please visit:
https://www.isam2026rotterdam.org/gatid-2026/
